Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancer

FDA Gives Mobocertinib Accelerated Approval for EGFR+ Lung Cancer

Revised Guidelines Perpetuate Disparities in Lung Cancer Screening

Lung Cancers: New Findings May Pave Way for New Therapeutic Drug Targets

The sensitive role of autophagy in cancer progression

Use of Common Meds Tied to Lower Lung Cancer Mortality Combined use of aspirin, statins, metformin tied to lower lung cancer risk and mortality

Atezolizumab Prolongs Survival in NSCLC With PD-L1 Expression Overall survival longer than for chemotherapy in metastatic NSCLC with high PD-L1 expression

Immunotherapy Drug Atezolizumab Beats Standard Chemo for Certain Lung Cancer Patients

Lung Cancer Treatment Plans Changed Due to Pandemic – 57 percent of patients receiving active treatment had at least one change in treatment plans

Study: Common immune cell linked to failure of checkpoint inhibitors in lung cancer